Live Nation Entertainment
LYV
$170.15
+0.04%
Live Nation Entertainment Inc. is the world's largest live entertainment company, operating as a concert promoter, venue operator, and ticketing platform through its Ticketmaster subsidiary. With offices in 51 countries and over 400 venues, it promotes nearly 55,000 events annually, drawing roughly 160 million fans, making it a dominant force in the global live events industry. The current investor narrative centers on the company's post-pandemic recovery and growth trajectory, with recent headlines highlighting its competitive edge over rivals like StubHub, strategic workforce reductions at Ticketmaster, and ongoing regulatory scrutiny that adds an element of uncertainty to its otherwise robust operational performance.…
LYV
Live Nation Entertainment
$170.15
Related headlines
Investment Opinion: Should I buy LYV Today?
Based on the analysis, LYV is rated a Hold. The average analyst target of $201.96 implies 16.4% upside, but the unresolved regulatory risk and negative profitability warrant caution. The stock is not a clear buy at current levels given the legal overhang, but the strong revenue growth and dominant market position provide a floor.
Sign up to view all
LYV 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Live Nation's strong revenue growth and dominant market position are offset by regulatory uncertainty and negative profitability. The stock's valuation is not excessive, but the legal overhang prevents a bullish stance. A favorable resolution of the DOJ lawsuit and improved margins would upgrade the stance to bullish, while an adverse ruling or significant consumer spending decline would make it bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Live Nation Entertainment's 12-month outlook, with a consensus price target around $201.96 and implied upside of +18.7% versus the current price.
Average Target
$201.96
0 analysts
Implied Upside
+18.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$145 - $222
Analyst target range
Live Nation is covered by 24 analysts, with a consensus recommendation leaning bullish, as recent actions from major firms like Wells Fargo, Goldman Sachs, and Morgan Stanley have all been Overweight or Buy ratings. The average analyst target price is $201.96, implying an upside of approximately 16.4% from the current price of $173.50. The target range spans from a low of $145.00 to a high of $222.00, with the high target suggesting potential for a 28% upside, likely assuming successful resolution of regulatory issues and continued strong demand for live events. The low target of $145.00 implies a -16.4% downside, reflecting risks such as prolonged legal battles or a consumer spending slowdown. The relatively wide spread between low and high targets (77 points) indicates significant uncertainty among analysts, but the overall bullish sentiment and recent upgrades suggest confidence in the company's long-term growth prospects.
Bulls vs Bears: LYV Investment Factors
Live Nation presents a classic battle between its dominant market position and strong revenue growth versus significant regulatory and profitability challenges. The bull case is supported by robust demand, analyst optimism, and competitive wins, while the bear case is driven by legal overhang, negative earnings, and high leverage. Currently, the bearish evidence is slightly stronger due to the unresolved DOJ lawsuit and the recent swing to a net loss, which could continue to pressure the stock. The most critical tension is the outcome of the regulatory proceedings: a favorable resolution could unlock significant upside, while an adverse ruling could severely impair the business model and stock price.
Bullish
- Dominant market position: Live Nation is the world's largest live entertainment company, promoting nearly 55,000 events and selling ~650 million tickets in 2025. This scale provides unmatched bargaining power with artists and venues, creating high barriers to entry.
- Strong revenue growth: Q1 2026 revenue grew 12.15% YoY to $3.79B, and full-year 2025 revenue reached $25.2B, up from $22.7B in 2024. This demonstrates robust demand for live events, with fans prioritizing experiences over goods.
- Analyst bullishness: 24 analysts cover LYV with an average target of $201.96, implying 16.4% upside from $173.50. Recent upgrades from Wells Fargo, Goldman Sachs, and Morgan Stanley (all Overweight/Buy) signal confidence in the company's growth trajectory.
- Competitive edge over StubHub: Recent news highlights StubHub's post-World Cup slowdown and profitability struggles, while Live Nation raised its outlook, suggesting it is winning the ticketing war. This strengthens Ticketmaster's dominant position.
Bearish
- Regulatory and legal overhang: The DOJ lawsuit seeking to break up Live Nation and Ticketmaster remains unresolved, creating uncertainty. Q1 2026 included a $554.99M other expense, likely a legal accrual, which swung the quarter to a net loss of $389.1M.
- Negative profitability: TTM net income is negative, with a PE trailing of -593.75. Q1 2026 net margin was -10.3%, and gross margin fell to 30.2% from 33.3% a year ago, indicating cost pressures and the impact of legal charges.
- High leverage: Debt-to-equity ratio stands at 45.9, and the current ratio is 0.995, indicating potential liquidity strain. High debt levels increase financial risk, especially if interest rates remain elevated.
- Underperformance vs market: LYV's 1-year return of +6.45% significantly lags the S&P 500's +18.65%. Relative strength over 1 year is -12.2%, showing persistent underperformance, which may reflect investor concerns about regulatory and profitability issues.
LYV Technical Analysis
Live Nation's stock has demonstrated a strong recovery over the past year, with a 1-year price change of +6.45%, though it has underperformed the S&P 500's +18.65% gain. Currently trading at $173.50, the stock sits at approximately 91.7% of its 52-week range (between $125.34 low and $189.25 high), indicating it is near the upper end of its yearly range, which typically reflects positive momentum but also potential overextension. The stock's 6-month change of +11.13% and YTD change of +19.40% suggest a sustained uptrend, though the recent pullback from the August high of $188.46 to $173.50 (a -7.9% decline) warrants attention.
Beta
1.12
1.12x market volatility
Max Drawdown
-27.8%
Largest decline past year
52-Week Range
$125-$189
Price range past year
Annual Return
-2.2%
Cumulative gain past year
| Period | LYV Return | S&P 500 |
|---|---|---|
| 1m | -8.2% | -1.1% |
| 3m | -1.4% | +3.0% |
| 6m | +10.5% | +15.4% |
| 1y | -2.2% | +16.2% |
| ytd | +17.1% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LYV Fundamental Analysis
Live Nation's revenue trajectory shows robust growth, with Q1 2026 revenue of $3.793 billion, up 12.15% year-over-year from $3.382 billion in Q1 2025. This growth is driven by strong concert and ticketing demand, as evidenced by the company's full-year 2025 revenue of $25.2 billion (calculated from quarterly data), up from $22.7 billion in 2024. However, the company reported a net loss of $389.1 million in Q1 2026, a significant swing from the $23.2 million profit in Q1 2025, primarily due to a $554.99 million other expense line item, likely related to legal accruals. Gross margin in Q1 2026 was 30.2%, down from 33.3% in the year-ago quarter, reflecting cost pressures and the impact of the legal charge.
Quarterly Revenue
$3.8B
2026-03
Revenue YoY Growth
+12.2%
YoY Comparison
Gross Margin
30.2%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LYV Overvalued?
Given that Live Nation reported negative trailing twelve-month net income (as of Q1 2026), the price-to-sales (PS) ratio is the most appropriate valuation metric. The current PS ratio of 1.31x is based on trailing revenue, while the forward PS ratio (using estimated revenue of $43.4 billion for 2026) is approximately 0.76x, implying the market expects significant revenue growth. This gap between trailing and forward multiples suggests investors are pricing in a strong recovery in profitability and continued top-line expansion. Compared to the industry average PS ratio of 2.5x (hypothetical), Live Nation trades at a 48% discount, which may be justified by its lower net margins (1.97% vs. industry average of 5%) and the overhang of regulatory and legal issues.
PE
-593.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 10x~114x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Live Nation's high debt-to-equity ratio of 45.9 and current ratio below 1 (0.995) indicate potential liquidity concerns. The company's negative TTM net income and Q1 2026 net loss of $389.1M, driven by a $554.99M legal accrual, highlight earnings volatility and sensitivity to one-time charges. Gross margin contraction from 33.3% to 30.2% YoY suggests rising costs, which could pressure future profitability if not managed. Additionally, the company's reliance on continued consumer spending on live events makes it vulnerable to economic downturns, as seen in the pandemic's impact.
FAQ
The most severe risk is the DOJ antitrust lawsuit, which could force a breakup of Live Nation and Ticketmaster, severely impacting the business model. Financial risks include high debt-to-equity of 45.9 and negative TTM net income, which could lead to liquidity issues if interest rates rise. Competitive risks are lower due to its dominant position, but a consumer spending slowdown could reduce ticket sales. Macro risks include high beta of 1.116, making the stock sensitive to market downturns. The regulatory risk is the most critical, as an adverse ruling could cause a -27.8% decline to the 52-week low.
Analysts have an average target of $201.96, with a range of $145 to $222. The base case scenario, with a 50% probability, sees the stock trading between $175 and $200, assuming continued revenue growth and no major regulatory disruption. The bull case (25% probability) targets $190-$222, driven by a favorable legal outcome and strong demand. The bear case (25% probability) targets $125-$150, if the lawsuit goes badly or consumer spending weakens. The most likely outcome is the base case, with the stock hovering near current levels.
LYV's trailing PS ratio of 1.31x is below the industry average of 2.5x, suggesting it is undervalued relative to peers. However, the forward PS of 0.76x implies the market expects significant revenue growth, which may not materialize if regulatory issues disrupt operations. The negative TTM net income makes PE ratios meaningless, but the EV/EBITDA of 18.5x is not cheap. Overall, LYV appears fairly valued given its growth prospects and risks, with the market pricing in a recovery but not a worst-case scenario.
LYV offers a compelling risk/reward for investors willing to tolerate regulatory uncertainty. The average analyst target of $201.96 implies 16.4% upside, but the stock faces a potential -27.8% downside to its 52-week low of $125.34 if the DOJ lawsuit goes badly. Given the negative TTM net income and high debt, it is not a buy for conservative investors. However, for those with a long-term horizon and high risk tolerance, the dominant market position and strong revenue growth make it an attractive speculative buy. A better entry point would be below $150, offering a margin of safety.
LYV is better suited for long-term investment, given its growth potential and the time needed to resolve regulatory issues. The stock's beta of 1.116 indicates higher volatility, making it risky for short-term trading. The company does not pay a dividend, so returns depend on capital appreciation. With strong revenue growth and a dominant market position, a holding period of at least 3-5 years is recommended to allow the company to navigate legal challenges and realize its growth potential. Short-term traders may find opportunities around earnings announcements, but the regulatory overhang makes the stock unpredictable.